Use of reclassification for assessment of improved prediction: an empirical evaluation
The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An increasing number of studies evaluate the ability of predictors to change risk stratification and alter medical decisions, i.e. reclassification performance. We examined the reported design and analysis of recent studies of reclassification and the robustness of their claims for improved reclassification. METHODS: Two independent investigators searched PubMed and citations to the article that introduced the currently most popular reclassification metric (net reclassification index, NRI) to identify studies performing reclassification analysis (January 2006-January 2010). We focused on articles that included any analyses comparing the performance of a baseline predictive model vs the baseline model plus some additional predictor for a prospectively assessed outcome. We recorded information on the baseline model used, outcomes assessed, choice of risk thresholds and features of reclassification analyses. RESULTS: Of 58 baseline models used in 51 eligible papers, only 14 (24%) were previously described, used as described and had same outcomes as originally intended. Calibration was examined in 53% of the studies. Sixteen studies (31%) provided a reference for the choice of risk thresholds and only six used the previously proposed categories or justified the use of alternative thresholds. Only 14 studies (27%) stated that the chosen risk thresholds had different therapeutic intervention implications. NRI was calculated in 38 studies and was smaller in studies with adequately referenced or justified risk thresholds vs others (P < 0.0001). CONCLUSIONS: Reclassification studies would benefit from more rigorous methodological standards; otherwise claims for improved reclassification may remain spurious.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While making revisions, conscious efforts were made to harmonize our recommendations with other reporting guidelines, and where possible we chose the same or similar wording for items (37,39,41,45,46).”
From Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement (2015) · cites this paper as [41]
In the citing paper
“the focus of the REMARK checklist is primarily on prognostic factors and not prediction models, whereas the GRIPS statement is aimed at risk prediction using genetic risk factors and the specific methodological issues around handling large numbers of genetic variants.”
From Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement (2015) · cites this paper as [41]
In the citing paper
“The reporting of studies evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models [18,42], also fits entirely within the remit of TRIPOD (see the accompanying explanation and elaboration document [43]).”
From Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement (2015) · cites this paper as [42]
In the citing paper
“An ever-increasing number of studies are evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models [18,42].”
From Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement (2015) · cites this paper as [42]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
Cited by
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Self-citationCollins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BMJ · doi:10.1136/bmj.g7594 · Cited by 4,388
“The reporting of studies evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models (18, 42), also fits entirely within the remit of TRIPOD (see the accompanying explanation and elaboration document [43], available at www .”
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.639 · Cited by 3,293
“An ever-increasing number of studies are evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models (Tzoulaki et al, 2011; Steyerberg et al, 2012).”
InfluentialCollins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0697 · Cited by 3,267
“The reporting of studies evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models [18,42]; also fits entirely within the remit of TRIPOD (see the accompanying explanation and elaboration document [43]; available at www.”
BackgroundCollins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. (2015) · BMC Medicine · doi:10.1186/s12916-014-0241-z · Cited by 1,927
“The reporting of studies evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models [18,42], also fits entirely within the remit of TRIPOD (see the accompanying”
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Surgery · doi:10.1002/bjs.9736 · Cited by 889
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Circulation · doi:10.1161/circulationaha.114.014508 · Cited by 793
“prediction models (18, 42), also fits entirely within the remit of TRIPOD (see the accompanying explanation and elaboration document [43], available at www .”
Leening, M. J. G., Vedder, M. M., Witteman, J. C. M., Pencina, M. J., & Steyerberg, E. W. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1522 · Cited by 594
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · European Urology · doi:10.1016/j.eururo.2014.11.025 · Cited by 439
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.11.010 · Cited by 324
“…reporting of studies evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models [18,42], also fits entirely within the remit of TRIPOD (see the accompanying explanation and elaboration document [43], available at www.annals.org).”
Comparisons of established risk prediction models for cardiovascular disease: systematic review
Siontis, G. C. M., Tzoulaki, I., Siontis, K. C., & Ioannidis, J. P. A. (2012) · BMJ · doi:10.1136/bmj.e3318 · Cited by 300
Self-citationTzoulaki, I., Ebbels, T. M. D., Valdes, A., Elliott, P., & Ioannidis, J. P. A. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu143 · Cited by 183
Self-citationNew Metrics for Assessing Diagnostic Potential of Candidate Biomarkers
Pickering, J. W., & Endre, Z. H. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09590911 · Cited by 173
“A Hosmer–Lemeshow goodness of fit was used to test calibration of the model (5).”
BackgroundMethodInfluentialCollins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13244 · Cited by 207
Bias in Associations of Emerging Biomarkers With Cardiovascular Disease
Tzoulaki, I., Siontis, K. C., Evangelou, E., & Ioannidis, J. P. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3018 · Cited by 108
Self-citationTzoulaki, I., Siontis, K. C. M., & Ioannidis, J. P. A. (2011) · BMJ · doi:10.1136/bmj.d6829 · Cited by 80
Self-citationScrutinio, D., Ammirati, E., Guida, P., Passantino, A., Raimondo, R., Guida, V., Braga, S. S., Pedretti, R. F. E., Lagioia, R., Frigerio, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.005 · Cited by 76
Minimal and Null Predictive Effects for the Most Popular Blood Biomarkers of Cardiovascular Disease
Ioannidis, J. P. A., & Tzoulaki, I. (2012) · Circulation Research · doi:10.1161/res.0b013e31824da8ad · Cited by 69
Self-citationBao, W., Hu, F. B., Rong, S., Rong, Y., Bowers, K. A., Schisterman, E. F., Liu, L., & Zhang, C. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt123 · Cited by 75
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12376 · Cited by 58
Carlsson, A. C., Risérus, U., Engström, G., Ärnlöv, J., Melander, O., Leander, K., Gigante, B., Hellénius, M.-L., & Fairé, U. D. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.46 · Cited by 63
Cardiac Biomarkers and Acute Kidney Injury After Cardiac Surgery
Bucholz, E. M., Whitlock, R. P., Zappitelli, M., Devarajan, P., Eikelboom, J. W., Garg, A. X., Thiessen‐Philbrook, H., Devereaux, P. J., Krawczeski, C. D., Kavsak, P. A., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-2949 · Cited by 59
Leening, M. J. G., Steyerberg, E. W., Van Calster, B., D'Agostino, R. B., & Pencina, M. J. (2014) · Statistics in Medicine · doi:10.1002/sim.6133 · Cited by 53
“Markers are typically added to models which contain a limited number of well-known predictors [11].”
BackgroundThomas, L. E., O'Brien, E. C., Piccini, J. P., D’Agostino, R. B., & Pencina, M. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy345 · Cited by 62
“Recent literature reviews have found that risk cut-offs tend to be poorly motivated, rarely correspond to clear treatment decisions, and consequently yield inflated NRI values.(7,32) In the ORBIT-AF example, the three-category NRIs range from 0 to 0.”
BackgroundGrunkemeier, G. L., & Jin, R. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.10.084 · Cited by 41
Kerr, K. F., Bansal, A., & Pepe, M. S. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws210 · Cited by 35
“The NRI(>0) and its category-based variants have recently become very popular (4).”
BackgroundLiman, T., Zietemann, V., Wiedmann, S., Jungehuelsing, G. J., Endres, M., Wollenweber, F. A., Wellwood, I., Dichgans, M., & Heuschmann, P. U. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00871.x · Cited by 37
Mühlenbruch, K., Heraclides, A., Steyerberg, E. W., Joost, H., Boeing, H., & Schulze, M. B. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9744-0 · Cited by 40
“Unfortunately, categories of risk with different clinical indications have not been established for type 2 diabetes so far and varying cut-offs, number of categories and follow-up durations were used to evaluate reclassification for diabetes prediction models, thus introduces subjectivity in this area [10].”
MethodMartinelli, N., Girelli, D., Baroni, M., Guarini, P., Sandri, M. F., Lunghi, B., Tosi, F., Branchini, A., Sartori, F. G., Woodhams, B. J., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13274 · Cited by 31
Walley, K. R. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0357-x · Cited by 28
Commentary: Reporting standards are needed for evaluations of risk reclassification
Pepe, M. S., & Janes, H. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr083 · Cited by 26
Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease
King, A., Wu, L., Deng, H., Shen, H., & Wu, C. (2022) · BMC Medicine · doi:10.1186/s12916-022-02583-y · Cited by 29
Bleeding Risk Prediction Models in Atrial Fibrillation
Thomas, I. C., & Sorrentino, M. J. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0432-9 · Cited by 26
“Using a popular though often criticized alternative analysis to c-statistics [32, 33], the authors showed that the net reclassification index (NRI) of HASBLED was statistically superior to the other risk models.”
ResultWhat to expect from net reclassification improvement with three categories
Pencina, K. M., Pencina, M. J., & D’Agostino, R. B. (2014) · Statistics in Medicine · doi:10.1002/sim.6286 · Cited by 23
Bohn, E., Tangri, N., Gali, B., Henderson, B. T., Sood, M. M., Komenda, P. V. J., & Rigatto, C. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-263 · Cited by 23
“To be judged clinically useful, the models incorporating AAC and CTR had to exhibit statistically significant improvements in two of the following three measures of predictive model performance: Cstatistic, IDI > 10%, and NRI > 10% [22,23].”
Perioperative cardiac biomarkers: the utility and timing
Beattie, W. S., & Wijeysundera, D. N. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283632f07 · Cited by 27
“Re-stated, the basic parameter for reliable biomarkers is the ability to re-allocate patients to both higher or lower risk categories [5].”
BackgroundThe accuracy of predicting cardiovascular death based on one compared to several albuminuria values
Hatlen, G., Romundstad, S., & Hallan, S. I. (2013) · Kidney International · doi:10.1038/ki.2013.500 · Cited by 20
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Diabetic Medicine · doi:10.1111/dme.12654 · Cited by 25
“An ever-increasing number of studies are evaluating the incremental value of specific predictors, beyond established predictors or even beyond existing prediction models (18, 42).”
van Smeden, M., & Moons, K. G. M. (2017) · Statistics in Medicine · doi:10.1002/sim.7286 · Cited by 18
“In such cases, one must ask: does a measure of movements in a reclassification table in which the reclassifications have no impact on decision-making inform us about the predictive potential of a novel biomarker? Both the importance and difficulties of defining clinically meaningful threshold values for categorical NR…”
BackgroundSimpson's paradox in the integrated discrimination improvement
Chipman, J., & Braun, D. (2016) · Statistics in Medicine · doi:10.1002/sim.6862 · Cited by 18
Waldron, N. H., Cooter, M. L., Piccini, J. P., Anstrom, K. J., Klinger, R. Y., Kertai, M. D., Podgoreanu, M. V., Stafford‐Smith, M., Newman, M. F., & Mathew, J. P. (2018) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-018-1119-x · Cited by 16
Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations
Strassmann, A., Frei, A. L., Haile, S. R., ter Riet, G., & Puhan, M. A. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.09.003 · Cited by 12
“Finally, thresholds have a strong impact on reclassification, and inadequate use of threshold may lead to larger estimates of improved reclassifications.(48) As far as we know from the literature, there are no evidencebased risk thresholds for COPD exacerbation, and our choices had to be arbitrary.”
BackgroundInvited Commentary—Genetic Prediction for Common Diseases
Ioannidis, J. P. A. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.931 · Cited by 10
Self-citationKrittayaphong, R., Chichareon, P., Komoltri, C., Sairat, P., & Lip, G. Y. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041265 · Cited by 9
“The Net Reclassification Index (NRI) and Integrated Discrimination Index (IDI) was performed based on the previously proposed methods to determine the influence of the predictive model on the reclassification of the study subjects [23].”
MethodWu, W., Deng, Z., Wahafu, A., Wang, Y., Xiang, J., Zhu, L., Li, B., Wang, M., & Wang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01750 · Cited by 9
“The choice of final prediction model was determined by AIC, the ROC curve, the C-index, and the IDI, which were also used to examine efficiency of the models (Table 2 and Figures 1G–”
MethodInfluentialMoons, K. G. M., Altman, D. G., Reitsma, J. B., loannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2022) · Digital Diagnostics · doi:10.17816/dd110794 · Cited by 10
Achhra, A. C., Amin, J., Sabin, C. A., Chu, H., Dunn, D. T., Kuller, L. H., Kovacs, J. A., Cooper, D. A., Emery, S., & Law, M. G. (2012) · AIDS · doi:10.1097/qad.0b013e328355d659 · Cited by 8
“widely adopted in cardiovascular and cancer literature [25–27] and is being increasingly used in other areas of research [28].”
Krittayaphong, R., Apiyasawat, S., Methavigul, K., Komoltri, C., & Lip, G. Y. H. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.04.062 · Cited by 9
Roelen, C. A. M., Bültmann, U., Groothoff, J. W., Twisk, J. W. R., & Heymans, M. W. (2015) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-015-1032-3 · Cited by 9
“Empirical evaluations of the literature showed that reclassification methods and measures are often applied inappropriately, for example, to assess the performance of new prognostic models that differ from the previously established models (Tzoulaki et al. 2011; Bouwmeester et al. 2012).”
BackgroundDemler, O., Paynter, N. P., & Cook, N. R. (2018) · Diagnostic and Prognostic Research · doi:10.1186/s41512-018-0034-5 · Cited by 6
“When risk stratification is of interest, a relevant question is how adding a given biomarker to a risk model affects clinical decision making [11].”
BackgroundMethodTang, H., Liu, X., He, P., Deng, F., Zhu, D., Ge, B., & Lei, S. (2024) · Clinical and Molecular Epidemiology · doi:10.53964/cme.2024003 · Cited by 4
Krittayaphong, R., Winijkul, A., Rungpradubvong, V., Apiyasawat, S., Phrommintikul, A., Chantrarat, T., Methavigul, K., Chichareon, P., Makarawate, P., Wongtheptien, W., et al. (2025) · JACC Asia · doi:10.1016/j.jacasi.2024.10.027 · Cited by 7
The Use of Genetic Information in the Prediction of Type 2 Diabetes
Drenos, F. (2015) · Personalized Medicine · doi:10.2217/pme.15.19 · Cited by 4
Huang, Q., Li, S., Chen, X., Liu, X., Zhou, G., Huang, L., Li, X., Lin, K., & Zheng, X. (2023) · Journal of Cancer · doi:10.7150/jca.85301 · Cited by 4
“Third, the model was evaluated using receiver operating characteristic (ROC) curves, Harrell’s concordance index (C-index), net reclassification index (NRI), and integrated discrimination index (IDI) [24].”
MethodPang, C. L., Pilkington, N., Wei, Y., Peters, J., Roobottom, C. A., & Hyde, C. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0777-5 · Cited by 3
“Our investigation on AUC [15] and NRI [17] were not empirical and can only serve as an update in a different population.”
BackgroundMethodResultInfluentialPumprueg, S., Lip, G. Y. H., Komoltri, C., Yindeengam, A., & Krittayaphong, R. (2026) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-026-03333-0 · Cited by 1
Labarère, J., & Raskovalova, T. (2012) · Références en médecine d'urgence · doi:10.1007/978-2-8178-0297-8_5 · Cited by 1
Moons, K. G. M., Altman, D. G., Reitsma, J. B., loannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2023) · Вопросы современной педиатрии · doi:10.15690/vsp.v22i2.2557 · Cited by 1
Cardiovascular risk prediction in the Netherlands
van Dis, S. J. (2011) · doi:10.18174/186623 · Cited by 1
A minimal net reclassification improvement to assess predictions of intensive care mortality
Tandjaoui-Lambiotte, Y., Lambert, J., & Chevret, S. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280212459389
“Reclassification measures have already been applied in an increasing number of clinical settings.(13) However, more effort has been reported to be needed in exploring their properties in practical situations before they can be universally recommended.”
BackgroundBiomarkers, Genetic Association, and Genomic Studies
Dorak, M. T., & Yazıcı, Y. (2014) · Springer eBooks · doi:10.1007/978-3-319-08374-2_4
Zhao, Y., Li, D., Deng, X.-W., Xu, G.-Q., Lin, J., Zhang, Q., Zhu, P., Wu, H.-L., Wang, X., & Chen, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4421138/v1
Kommentar zu „Biomarker zeigen prognostischen Wert bei kardiovaskulärer Primärprävention“
Laufs, U., & Stegmann, T. (2025) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2368-0978
Cardiovascular risk prediction in Central and Eastern Europe and former Soviet Union
Vikhireva, O. (2012) · UCL Discovery (University College London)
King, A., Wu, L., HongWen, D., Shen, H., & Wu, C. (2022) · Figshare · doi:10.6084/m9.figshare.21510510
King, A., Wu, L., HongWen, D., Shen, H., & Wu, C. (2022) · Figshare · doi:10.6084/m9.figshare.21510504
King, A., Wu, L., HongWen, D., Shen, H., & Wu, C. (2022) · Figshare · doi:10.6084/m9.figshare.21510501
King, A., Wu, L., HongWen, D., Shen, H., & Wu, C. (2022) · Figshare · doi:10.6084/m9.figshare.21510507
King, A., Wu, L., HongWen, D., Shen, H., & Wu, C. (2022) · Figshare · doi:10.6084/m9.figshare.21510498
Liu, C., Huang, R., Hong, J., Chen, W., Hao, Y., Zhu, B., Tan, M., Li, Y., 王奕淳, Zhang, H., et al. (2026) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-026-09932-5
“This association may reflect the adverse effects of reduced mobility on both intestinal function and venous return, as immobility can impair bowel peristalsis and contribute to constipation [35], while simultaneously promoting venous stasis [36].”
Metadata
- Authors
- Tzoulaki, I., Liberopoulos, G., & Ioannidis, J. P. A.
- Affiliations
- Imperial College London (GB)
- Tufts University (US)
- Corresponding author
- Ioannidis, John P A
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-16
- Volume
- 40
- Issue
- 4
- Pages
- 1094-1105
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2106597074
- Cited by
- 70
- References
- 93
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 7 · 2020: 1 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 16 · 2014: 5 · 2013: 9 · 2012: 11
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- reclassification, net reclassification improvement, risk stratification, risk thresholds, calibration, risk prediction model, methodological quality, prediction model evaluation
- MeSH terms
- Chronic Disease, Humans, Risk Factors, Models, Statistical, Treatment Outcome, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.